-
Identifying mutations in patient-derived melanoma DCC lines
Study
EGAS50000001225
-
Eribulin efficacy in platinum-resistant and refractory high-grade serous ovarian cancer patient-derived xenograft models
Study
EGAS50000000152
-
Exome_sequencing_of_patients_with_Ewings_sarcoma_
Study
EGAS00001000266
-
Parallel Detections of Somatic Gene Mutations in Surgically Resected Tumor tissues and Matched Plasma Specimens in Early-Stages of Primary Breast Cancer
Study
EGAS00001003075
-
Whole genome bisulfite sequencing of prostate cancer samples upon oral pimonidazole administration
Study
EGAS50000000069
-
MediMer: A versatile do-it-yourself peptide-receptive MHC class I multimer platform for tumor neoantigen-specific T cell detection
Study
EGAS50000000065
-
Angiosarcoma_follow_up_2_validation_study
Study
EGAS00001000518
-
Breast_Cancer_Whole_Genome_Sequencing
Study
EGAS00001000210
-
RNA-Sequencing of cervical cancers
Study
EGAS50000000087
-
Cloning_of_the_breakpoint_of_a_novel_translocation_associated_with_T_acute_lymphoblastic_leukaemia
Study
EGAS00001000520
-
Metabolic requirements of the metastasis-initiating tumour cell population using oral squamous cell carcinoma (OSCC) as a model system
Study
EGAS00001004765
-
Cerebrospinal fluid cfDNA sequencing for classification of central nervous system glioma
Study
EGAS50000000060
-
Ewings Sarcoma RNA-Seq
Study
EGAS00001003062
-
Histone chaperone CHAF1A promotes proliferation and tumorigenicity in gastric cancer and impacts prognosis via context-depedent regulation of gene expression
Study
EGAS00001003064
-
BS-seq in plasma of CRC patients
Study
EGAS00001003117
-
AVENIO Expanded ctDNA panel sequence alignments (BAMs) from plasma DNA of lung cancer patients from the OSCILLATE trial
Study
EGAS50000000103
-
Immunomodulatory effects and improved outcomes with cisplatin- vs carboplatin-based chemotherapy plus atezolizumab in urothelial cancer
Study
EGAS50000000104
-
Transcriptomic profiles of early and late passage metastatic colorectal cancer (mCRC) tumoroids
Study
EGAS50000000108
-
Clones derived from early passage tumoroids of colorectal cancer
Study
EGAS50000000107
-
Altered enhancer-promoter interaction leads to MNX1 expression in pediatric acute myeloid leukemia with t(7;12)(q36;p13)
Study
EGAS50000000130
-
Efficacy and safety of entrectinib in patients with ROS1-positive advanced/metastatic non-small cell lung cancer (NSCLC) from the Blood First Assay Screening Trial (BFAST)
Study
EGAS50000000105
-
Low-coverage whole-sequencing of metastasised colorectal cancer samples treated with bevazicumab
Study
EGAS50000000131
-
Multiregion Whole-Exome Sequencing Uncovers the Genetic Evolution and Mutational Heterogeneity of Early-Stage Metastatic Melanoma.
Study
EGAS00001004320
-
Cancer-associated fibroblasts promote drug resistance in ALK-driven lung adenocarcinoma cells by upregulating lipid biosynthesis
Study
EGAS50000000135
-
Activating AKT1 and PIK3CA mutations in metastatic castration-resistant prostate cancer
Study
EGAS00001004328
-
SCANDARE MACARON
Study
EGAS50000000145
-
Small‑scale mutations are infrequent as mechanisms of resistance in post‑PARP inhibitor tumour samples in high grade serous ovarian cancer
Study
EGAS50000000146
-
Whole exome sequencing of bladder tumors
Study
EGAS50000001248
-
RNA-seq of Glioblastoma stem cells
Study
EGAS00001003070
-
Genome-wide NanoRCS sequencing of cfDNA and ctDNA from liquid biopsies of healthy individuals and cancer patients
Study
EGAS50000000154
-
BIG_MS_Pilot
Study
EGAS00001000616
-
Deregulation of FOXF1/FENDRR from t(14;16)(q32;q24) defines a subtype of high risk lineage ambiguous leukemia
Study
EGAS50000001255
-
Oxidative DNA damage and ubiquitin proteasome system dysfunction underpins neurodegeneration in young adults with a DNA repair disorder
Study
EGAS50000000158
-
Longitudinal copy number variation analysis from plasma DNA of head and neck cancer patients under re-radiotherapy
Study
EGAS50000000163
-
Somatic_mutation_and_clonal_evolution_in_the_human_testes
Study
EGAS00001003021
-
Immune heterogeneity in small cell lung cancer and vulnerability to immune checkpoint blockade
Study
EGAS50000000138
-
Residual ANTXR1+ myofibroblasts after chemotherapy inhibit anti-tumor immunity via YAP1 signaling pathway
Study
EGAS50000000136
-
Evolutionary Trajectories of Small Cell Lung Cancer under Therapy
Study
EGAS50000000169
-
Single-cell transcriptomic analyses of peripheral blood mononuclear cells, peritoneal fluid, and peritoneal metastases from patients with colorectal cancer
Study
EGAS50000000173
-
Neoadjuvant atezolizumab plus chemotherapy in gastric and gastroesophageal junction adenocarcinoma: the phase 2 PANDA trial
Study
EGAS50000000168
-
Stability of gut microbiome after COVID-19 vaccination in healthy and immuno-compromised individuals
Study
EGAS50000000179
-
Exome sequencing of early and late passage Patient Derived Xenogratf Tumoroids with matched Patient Derived Xenogratfs and matched normal liver
Study
EGAS50000000185
-
Somatic point mutation data from microsatellite unstable colorectal cancers
Study
EGAS00001003101
-
Oxidative DNA damage and ubiquitin proteasome system dysfunction underpins neurodegeneration in young adults with a DNA repair disorder
Study
EGAS50000000160
-
Oxidative DNA damage and ubiquitin proteasome system dysfunction underpins neurodegeneration in young adults with a DNA repair disorder
Study
EGAS50000000162
-
Origin of second malignancies in children
Study
EGAS50000000167
-
Recurrent loss of heterozygosity correlates with clinical outcome in pancreatic neuroendocrine cancer
Study
EGAS00001003038
-
Karyotype Evolution in Response to Chemoradiotherapy and Upon Recurrence of Esophageal Adenocarcinomas
Study
EGAS00001007711
-
A Genomics-Based Classification of Human Lung Tumors
Study
EGAS00001000647
-
Circulating cell-free DNA analysis in Small Cell Lung Cancer
Study
EGAS00001003110
-
Frequent mutation of the FOXA1 untranslated region in prostate cancer
Study
EGAS00001003113
-
Shallow Whole Genome Sequencing of Patient Derived Xenografts
Study
EGAS50000000191
-
Low and variable tumor reactivity of the intratumoral TCR repertoire in human cancers
Study
EGAS00001003119
-
Microbiome confounders and quantitative profiling challenge established microbial targets in colorectal cancer developmental stages
Study
EGAS00001007413
-
cell-Free DNA Genomic Profiling and its Clinical Implementation in Advanced Prostate Cancer
Study
EGAS50000000234
-
Renal_Follow_Up_Series
Study
EGAS00001000095
-
Comprehensive spatial landscape and plasticity of immunosuppressive fibroblasts in breast cancer
Study
EGAS50000000220
-
Single-cell atlas of penile cancer reveals TP53 mutations as driver for an aggressive phenotype, irrespective of HPV status, and provides clues for treatment personalization
Study
EGAS50000000217
-
Clonal Evolution and Blastic Plasmacytoid Dendritic Cell Neoplasm - Two Cases
Study
EGAS50000000214
-
Immune Biomarkers in Metastatic Castration-resistant Prostate Cancer
Study
EGAS50000001269
-
single-cell RNA-Seq of colorectal cancer patient samples
Study
EGAS00001006665
-
Dynamics of checkpoint receptors in γδ T cell subsets are associated with clinical responses during anti-PD-1 immunotherapies
Study
EGAS50000001270
-
Non-small cell lung cancer molecular subtypes and vulnerability to immunotherapy treatment combinations
Study
EGAS50000001272
-
Broad utility of ultrasensitive analysis of ctDNA dynamics across solid tumors treated with immunotherapy
Study
EGAS50000001271
-
BAP1 study
Study
EGAS50000000235
-
DNA Replication Speed controls Epigenome Integrity and T Cell Fate
Study
EGAS50000001273
-
Oxel Pilot Study
Study
EGAS50000000222
-
A comprehensive proteogenomic pipeline for neoantigen discovery to advance personalized cancer immunotherapy
Study
EGAS50000000228
-
Liquid biopsy for molecular characterization of diffuse large B-cell lymphoma and early assessment of minimal residual disease
Study
EGAS50000000215
-
Neversmoker lung adenocarcinoma
Study
EGAS50000000232
-
Whole exome DNA sequence profiling of spatial biopsies of high grade serous epithelial ovarian cancer
Study
EGAS00001003048
-
Transcriptomic characterization of the histopathological growth patterns in breast cancer liver metastases
Study
EGAS50000000225
-
Targeted re-sequencing of multi-region sampled tumors in PDAC
Study
EGAS50000000239
-
Improved detection of colibactin-induced mutations by genotoxic E. coli in organoids and colorectal cancer
Study
EGAS50000000212
-
Detailed molecular and immune marker profiling of archival prostate cancer samples
Study
EGAS00001004396
-
GBM stem cell lines and PRMT5 inhibitor
Study
EGAS00001004397
-
Microdissection_sequencing_of_normal_human_prostate
Study
EGAS00001003049
-
Prediction of plasma ctDNA fraction and prognostic implications of liquid biopsy in advanced prostate cancer
Study
EGAS50000000211
-
Sensitive circulating tumor DNA based residual disease detection in epithelial ovarian cancer
Study
EGAS50000000245
-
RNA sequencing of serial samples from patients enrolled in the NA-PHER2 trial
Study
EGAS50000000248
-
Localised colon cancer WES study contaning WBCs, tissue and plasma samples at different time points
Study
EGAS50000000204
-
Panel sequencing of endocrine-resistant breast cancer
Study
EGAS50000000236
-
Accelerated single cell seeding in relapsed multiple myeloma
Study
EGAS00001004404
-
A fast, affordable and minimally-invasive diagnostic test for Cancer of Unknown Primary (CUP) using DNA methylation profiling
Study
EGAS50000000257
-
DNTR sequencing data of paediatric acute lymphoblastic leukemia
Study
EGAS50000001247
-
Whole exome sequencing of small cell neuroendocrine cancer of the cervix
Study
EGAS00001003142
-
Mutational_Analysis_of_Colorectal_PDX_models
Study
EGAS00001001171
-
The polarity and specificity of antiviral T lymphocyte responses determine susceptibility to SARS-CoV-2 infection in cancer patients and healthy individuals.
Study
EGAS00001005985
-
Homopolymer switches mediate adaptive mutability in mismatch repair-deficient colorectal cancer
Study
EGAS50000000297
-
CD8-targeted IL-2 unleashes tumor-specific immunity in human cancer tissue by reviving the dysfunctional T cell pool
Study
EGAS00001007712
-
BRCA1 secondary splice-site mutations
Study
EGAS50000000022
-
WGS of cord blood hematopoietic stem and progenitor cells
Study
EGAS50000000288
-
STM4 - Mouliere et al, 2018. Enhanced detection of circulating tumor DNA by fragment size analysis
Study
EGAS00001004418
-
Somatic mutations of non-malignant T cells
Study
EGAS50000000237
-
INTEGRATIVE MOLECULAR ANALYSIS OF SKIN TUMORS FROM CYLD CUTANEOUS SYNDROME PATIENTS
Study
EGAS50000000247
-
Comprehensive peripheral blood immunoprofiling reveals five immunotypes with immunotherapy response characteristics in cancer patients
Study
EGAS50000000286
-
Molecular underpinnings of dedifferentiation and aggressiveness in chromophobe renal cell carcinoma
Study
EGAS50000000287
-
Whole Genome Sequencing of HER2-Positive Metastatic Extramammary Paget’s Disease: A Case Report
Study
EGAS50000000243
-
Whole Exome Sequencing of 60 tumor/normal matched liver Cancers (HCC)
Study
EGAS00001003063
-
Heterogeneity and evolution of DNA mutation rates in microsatellite-stable colorectal cancer
Study
EGAS50000000284